MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript

MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15.

Keep Reading →